Combating Carcinoma

Jyothi Menon, a PhD graduate of the dual program in bioengineering between UT Southwestern and UTA, is at the forefront of groundbreaking research aimed at combating hepatocellular carcinoma, the fastest-growing cause of cancer-related fatalities worldwide. This lethal disease is primarily linked to chronic alcohol liver disease.

Dr. Menon, now an associate professor at the University of Rhode Island College of Pharmacy, is spearheading an initiative to harness the power of specialized nanoparticles that can selectively pinpoint liver cells responsible for hepatic fibrosis, significantly enhance drug penetration into fibrotic liver tissue, administer vital medications, and orchestrate the timed release of therapeutics. ₪